Literature DB >> 24375161

Producing gelatin nanoparticles as delivery system for bovine serum albumin.

Bahareh Azimi1, Parviz Nourpanah1, Mohammad Rabiee2, Shahram Arbab3.   

Abstract

BACKGROUND: Progress in the field of biology and biochemistry has led to the discovery of numerous bioactive peptides and proteins in the last few decades. Delivery of therapeutic proteins/peptides has received a considerable amount of attention in recent years.
METHODS: In this study, a two-step desolvation method was used to produce biodegradable hydrophilic gelatin nanoparticles (GNP) as a delivery system of protein model (BSA). The size and shape of the nanoparticles were examined by dynamic light scattering and scanning electron microscopy.
RESULTS: Particles with a mean diameter of 200-300 nm were produced and the percentage of entrapment efficiency was found to be 87.4. The optimum amount of theoretical BSA loading was obtained, the release of BSA was monitored in vitro, and the mechanism of release was studied. The BSA release profile showed a biphasic modulation characterized by an initial, relatively rapid release period, followed by a slower release phase.
CONCLUSION: Results show that the two-step desolvation is an appropriate method for preparing GNP as a delivery vehicle for BSA.

Entities:  

Keywords:  Gelatin; Nanoparticles; Bovine serum albumin

Mesh:

Substances:

Year:  2014        PMID: 24375161      PMCID: PMC3892138          DOI: 10.6091/ibj.1242.2013

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN: 1028-852X


  18 in total

1.  Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate.

Authors:  A K Bajpai; Jyoti Choubey
Journal:  J Mater Sci Mater Med       Date:  2006-04       Impact factor: 3.896

Review 2.  Is the oral route possible for peptide and protein drug delivery?

Authors:  Mariko Morishita; Nicholas A Peppas
Journal:  Drug Discov Today       Date:  2006-09-07       Impact factor: 7.851

Review 3.  Recent advances in protein and peptide drug delivery systems.

Authors:  Dhirendra Kumar Malik; Sanjula Baboota; Alka Ahuja; Sohail Hasan; Javed Ali
Journal:  Curr Drug Deliv       Date:  2007-04       Impact factor: 2.565

4.  Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation.

Authors:  Eun Ju Lee; Saeed Ahmad Khan; Joong Kon Park; Kwang-Hee Lim
Journal:  Bioprocess Biosyst Eng       Date:  2011-09-10       Impact factor: 3.210

5.  Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method.

Authors:  J K Li; N Wang; X S Wu
Journal:  J Microencapsul       Date:  1998 Mar-Apr       Impact factor: 3.142

6.  Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system.

Authors:  Nader Taheri Qazvini; Sahar Zinatloo
Journal:  J Mater Sci Mater Med       Date:  2010-11-04       Impact factor: 3.896

Review 7.  Smart polymer based delivery systems for peptides and proteins.

Authors:  Khaled Al-Tahami; Jagdish Singh
Journal:  Recent Pat Drug Deliv Formul       Date:  2007

8.  Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate.

Authors:  Maria Grazia Cascone; Luigi Lazzeri; Claudia Carmignani; Zhouhai Zhu
Journal:  J Mater Sci Mater Med       Date:  2002-05       Impact factor: 3.896

9.  Gelatin nanocarriers as potential vectors for effective management of tuberculosis.

Authors:  Gaurav Kant Saraogi; Puspa Gupta; U D Gupta; N K Jain; G P Agrawal
Journal:  Int J Pharm       Date:  2009-10-09       Impact factor: 5.875

10.  Protein and Peptide drug delivery: oral approaches.

Authors:  Jessy Shaji; V Patole
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

View more
  4 in total

Review 1.  Comprehensive comparison of theranostic nanoparticles in breast cancer.

Authors:  Amin Nikdouz; Nima Namarvari; Ramin Ghasemi Shayan; Arezoo Hosseini
Journal:  Am J Clin Exp Immunol       Date:  2022-02-15

2.  Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model.

Authors:  Medhat A Al-Ghobashy; Aliaa N ElMeshad; Rania M Abdelsalam; Mohammed M Nooh; Muhammad Al-Shorbagy; Götz Laible
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

Review 3.  A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections.

Authors:  Abisola Abisoye-Ogunniyan; Isabella M Carrano; Dina R Weilhammer; Sean F Gilmore; Nicholas O Fischer; Sukumar Pal; Luis M de la Maza; Matthew A Coleman; Amy Rasley
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.988

4.  Fabrication of Encapsulated Gemini Surfactants.

Authors:  Bogumił Brycki; Adrianna Szulc; Iwona Kowalczyk; Justyna Brycka
Journal:  Molecules       Date:  2022-10-07       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.